Your Messages Inbox
Your Article Summary
See Latest ArticlesGenzyme Temporarily Interrupts Production at Allston Plant
Genzyme, 06/17/09
Genzyme Corporation announced that it has detected a virus that impairs cell growth in one of six bioreactors at its Allston Landing manufacturing facility. The company has decided to temporarily interrupt bulk production at the plant to sanitize the facility. Genzyme is collaborating with regulatory agencies as it works to resume production. The company expects the plant to be fully operational by the end of July.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
PLoS Medicine, 12/02/09
FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09
Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan
GlaxoSmithKline, 12/01/09
Article Search
Sponsor